DCTH Delcath: Bozor kapitallashuvining balans qiymatiga nisbati
Delcath Systems, Inc. (DCTH) hozirda talab juda yuqori bo'lgan AQSh tibbiyot markazlarida o'zining eksklyuziv jigar perfuziyasi usulini joriy etishni kengaytirmoqda. Metastaz terapiyasi dasturlarining xilma-xilligi operatsion risklarni minimallashtiradi. 4.14 miqdorida bo'lgan aksiya narxining bozor tendentsiyasi biznes tahlilini to'ldiradi. Delcath Systems, Inc. (DCTH) maqsadli dori yetkazib berish tizimlarini sotish orqali daromad keltiradi, sug'urta tashkilotlari esa asosiy xarajatlarni qoplaydi.
%20-%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_DCTH_-_Delcath-Systems-Inc._-_Market-Cap-to-Net-Assets-Ratio "DCTH Delcath Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
DCTH (Delcath Systems Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Fundamental baholash:DCTH (Delcath Systems, Inc.)
PHP tizimi uchun noyob patentlar va FDA ning qat'iy nazorati Delcath Systems, Inc. (DCTH) uchun yuqori ichki aktiv qiymatini yaratadi. Bozor qiymatining buxgalteriya qiymatiga nisbati grafigini tahlil qilish joriy aksiya narxini kompaniyaning sof kapitali bilan solishtirish imkonini beradi, bu esa aksiyaning moddiy aktivlariga nisbatan qadrsizlangan yoki haddan tashqari qimmatlanganligini aniqlaydi, nimaiki bu bozor tebranishlari davrida emitentning fundamental barqarorligini tasdiqlaydi.
Asosiy raqobatchilar
Bozor kapitallashuvining balans qiymatiga nisbati BeiGene Ltd ONC|halozyme.com (HALO) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|YMAB - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AURA|CADL (Candel Therapeutics, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ARAY - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati SELLAS Life Sciences Group Inc. (SLS)|Actuate Therapeutics (ACTU) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Citius Oncology Inc. (CTOR)|TuHURA Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|TARA - Kapitallashuvning sof aktivlarga nisbati|Fate Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|WHWK: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp|Bozor kapitallashuvining balans qiymatiga nisbati OS Therapies Incorporated OSTX|Kapitallashuvning balans qiymatiga nisbati Radiopharm Theranostics Ltd (RADX)|ARTV: Bozor kapitallashuvining balans qiymatiga nisbati|Adlai Nortye Ltd - Bozor qiymatining balans qiymatiga koeffitsiyenti|VERU - Bozor qiymatining balans qiymatiga nisbati|TPST - Bozor qiymatining balans qiymatiga nisbati|XLO (xiliotx.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Renovaro (RENB) - Kapitallashuvning sof aktivlarga nisbati|MURA (Mural Oncology PLC) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Kairos Pharma Inc (KAPA)|Kapitallashuvning sof aktivlarga nisbati OnKure Therapeutics Inc|Bozor kapitallashuvining balans qiymatiga multiplikatori w2.cytomed.sg (GDTC)|Bozor kapitallashuvining balans qiymatiga nisbati Curis|APLM - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Tharimmune (THAR)|ADVB: Balans qiymatiga nisbatan bozor qiymati|Genprex, Inc - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Calidi Biotherapeutics, Inc.|Kapitallashuvning sof aktivlarga nisbati SBFM (Sunshine Biopharma)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIO|SLRX (Salarius Pharmaceuticals, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Purple Biotech Ltd PPBT|Kapitallashuvning sof aktivlarga nisbati American Oncology Network, Inc. (AONC)|Bozor kapitallashuvining balans qiymatiga multiplikatori BeiGene Ltd BGNE|CKPT (Checkpoint Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|ELEV: Bozor qiymatining balans qiymatiga koeffitsiyenti|ICAD (icadmed.com) - Bozor qiymatining balans qiymatiga nisbati|IKNA (Ikena Oncology) - Kapitallashuvning sof aktivlarga nisbati|NTBL: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Viracta (VIRX)|MorphoSys AG (MOR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati nayabiosciences.com (NAYA)|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV